new glp-1 receptor agonists A Closer Look at the Dermatological Profile of Comparing Ozempic, Wegovy and Other
Description
Below are a few thoughts to consider as you plan for 2024 and beyond

doi: 10.1161/CIRCULATIONAHA.118.035901

Over half (55%) say they no longer participate in structured weight-loss programs like Weight Watchers or boot camps

doi: 10.1056/NEJMOA1603827 37 LeRNguyenMTAllahwalaMAPsaltisJPMaratheCSMaratheJAet al

Kristensen SL et al

Should the SELECT Trial make us comfortable using GLP-1 receptor agonists in HFrEF
